Media Centre
Latest press releases
-
Saphnelo approved in Japan for systemic lupus erythematosus
-
AstraZeneca COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases
-
Lynparza in combination with abiraterone significantly delayed disease progression in all-comers in PROpel Phase III trial in 1st-line metastatic castration-resistant prostate cancer
-
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
-
AstraZeneca to invest $360m in advanced manufacturing facility in Ireland
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director, Global Media Relations (Corporate)
+44 (0)1223 344 800
Angela Fiorin
Director, Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Chris Calland
Director, Global Media Relations (Oncology)
+44 (0)1223 344 800
Fiona Cookson
Director, Global Media Relations
(COVID-19 vaccine)
+44 (0)1223 344 800
Sinead Keller
Director, Global Media Relations
(COVID-19 vaccine)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
Holly Campbell
Head, US Corporate Communications
+1 302 885 2677
Lisa Taylor
Senior Director, Corporate Communications (Alexion)
+1 857 338 9025
Amanda Talamonte
Manager, Global Media Relations
+44 (0)1223 344 800
Flavia Garcia
Manager, Global Media Relations
+44 (0)1223 344 800
